Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
52,911
Sort by:
2024 World Hospital Hemostasis Diagnostics Market: Supplier Shares by Country, Emerging Tests, Technology Trends, Instrumentation Review, Sales Forecasts by Country, and Strategic Profiles of Leading Suppliers
US$ 6,500.00
This new report from LeadingMarketResearch provides an analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strat...
July 2024
-
Brazil Diabetes Market Report: 2024-2032
US$ 2,999.00
IMARC’s new report “Brazil Diabetes Market Report: 2019-2024” provides an analytical and statistical insight into the Brazil diabetes market. The report provides both current and future trends in the prevalence ...
July 2024
138 pages
Blood Plasma Derivatives Market Report by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032
US$ 2,999.00
The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of...
July 2024
145 pages
Cancer/Tumor Profiling Market Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Microarray, and Others), Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032
US$ 2,999.00
The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8....
July 2024
147 pages
Drug Screening Market Report by Product and Service (Equipment, Rapid Testing Devices, Consumables, Laboratory Services), Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Others), End User (Hospitals, Drug Testing Laboratories, Workplaces, Drug Treatment Centers, Pain Management Centers, Personal Users, Criminal Justice System and Law Enforcement Agencies), and Region 2024-2032
US$ 2,999.00
The global drug screening market size reached US$ 6.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during...
July 2024
149 pages
Early Toxicity Testing Market Report by Technique (In Vivo, In Vitro, In Silico), End User (Pharmaceuticals Industry, Food Industry, Chemicals Industry, Cosmetics Industry, and Others), and Region 2024-2032
US$ 2,999.00
The global early toxicity testing market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2%...
July 2024
140 pages
Blood Culture Tests Market - 2024-2031
US$ 3,400.00
Blood Culture Tests Market reached USD 8600.93 million in 2030 and, growing with a CAGR of 9.10% during the forecast period 2030-2035. The Blood Culture Tests Market emerges as a key focus in DataM In...
June 2024
45 pages
Blood Group Typing Market - 2024-2031
US$ 3,400.00
Blood Group Typing Marketis is growing with a CAGR of 9.20% during the forecast period 2026-2035. The Blood Group Typing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
June 2024
44 pages
2024 Europe Nucleic Acid Testing (NAT) Market Opportunities in France, Germany, Italy, Spain, UK--Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
US$ 17,500.00
This new five-country report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the E...
June 2024
-
